Form 4: Sanara MedTech Director Eric Tanzberger Receives Restricted Stock Grant Under 2024 Incentive Plan

Sanara MedTech Inc. Director Eric D. Tanzberger was granted 3,590 shares of restricted common stock as part of the company's 2024 Omnibus Long-Term Incentive Plan.

Summary

• Eric D. Tanzberger, a Director of Sanara MedTech Inc. (SMTI), acquired 3,590 shares of common stock on May 22, 2025.
• These shares were granted as restricted stock under the Sanara MedTech Inc. 2024 Omnibus Long-Term Incentive Plan.
• The shares were acquired at a price of $0, indicating a grant rather than a purchase.
• Following this transaction, Mr. Tanzberger beneficially owns 17,658 shares of common stock directly.
• The restricted shares are set to vest on the earlier of the 2026 annual shareholder meeting or May 22, 2026, contingent on Mr. Tanzberger continuing to provide services to the company.

Sentiment

Score: 7

Explanation: The grant of restricted stock to a director is generally a positive event as it aligns management's interests with shareholders, although it involves minor dilution. It's a routine compensation event.

Positives

• The grant of restricted stock aligns the director's interests with those of the shareholders, as the value of the compensation is tied to the company's future stock performance.
• The transaction is part of a pre-existing 2024 Omnibus Long-Term Incentive Plan, indicating a structured approach to executive and director compensation.

Negatives

• The issuance of new shares, even as restricted stock, can result in minor dilution for existing shareholders, though the amount in this specific grant is small.

Risks

• The vesting of the restricted stock is contingent upon the reporting person continuing to provide services to the company through the vesting date, meaning the shares are not immediately liquid or guaranteed.

Future Outlook

The future outlook for the granted shares is tied to their vesting schedule, which is expected to occur on the earlier of the 2026 annual shareholder meeting or May 22, 2026, provided the director continues to provide services to the company.

Management Comments

• The shares of restricted stock were granted by Sanara MedTech Inc. to the reporting person pursuant to the Sanara MedTech Inc. 2024 Omnibus Long-Term Incentive Plan.
• The shares of restricted stock will vest on the earlier of (i) the date of the 2026 annual shareholder meeting or (ii) May 22, 2026, provided that the reporting person is providing certain services to the Company through such date.

Industry Context

The grant of restricted stock to a director is a common practice in the healthcare and biotechnology industries, serving as a form of long-term incentive compensation designed to align the interests of company leadership with shareholder value creation.

Comparison to Industry Standards

• Restricted stock grants are a standard component of executive and director compensation packages across various industries, including healthcare and medical technology.
• The use of an Omnibus Long-Term Incentive Plan is a common corporate governance practice for managing equity-based compensation.
• Specific comparisons to other companies' grant sizes or vesting terms would require detailed analysis of their respective compensation plans, which is not provided in this Form 4 filing.

Corporate Governance

Related Party Transactions

• The transaction involves a grant of restricted stock from Sanara MedTech Inc. to Eric D. Tanzberger, a Director of the company, which constitutes a related party transaction.

Stakeholder Impact

• Shareholders: Experience minor dilution from the issuance of new shares, but benefit from increased alignment of the director's interests with long-term shareholder value.
• Director (Eric D. Tanzberger): Receives equity compensation, incentivizing continued service and performance tied to the company's stock value.

Next Steps

• The restricted shares granted to Eric D. Tanzberger are expected to vest on the earlier of the 2026 annual shareholder meeting or May 22, 2026, subject to continued service.

Key Dates

Keywords

Sanara MedTech Inc., SMTI, Restricted Stock, Stock Grant, Insider Transaction, Form 4, Director Compensation, Equity Incentive Plan, Beneficial Ownership